International immunopharmacology · 2025
METTL3-mediated m6A modification of circCSDE1 promote Coxsackievirus replication by regulating the miR-891b/BAG3 axis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Lulu, Wang Hua, Liu Tingjun, Zhou Xiaoxiang, Kuai Shougang, Ji Zengjun, Shen Hongxing
Аннотация
Coxsackievirus (CV), a major etiological agent of pediatric hand-foot-mouth disease and viral myocarditis, exploits host epigenetic mechanisms to facilitate pathogenesis. While N6-methyladenosine (m6A) modification and circular RNAs (circRNAs) are emerging as critical regulators of viral infections, their interplay in CV pathogenesis remains unexplored. Through methylated RNA immunoprecipitation sequencing (MeRIP-seq) validation, we identified hsa_circ_0000115 (circCSDE1) as a viral-inducible circRNA significantly upregulated during CVB3 and CVA16 infection. Mechanistically, CVB infection triggered METTL3-dependent m6A hypermethylation of circCSDE1 precursor RNA, enhancing its cyclization efficiency and nuclear export. Functional studies revealed that circCSDE1 acts as a competitive endogenous RNA to sequester miR-891b, thereby de-repressing BAG3 expression and activating pro-viral autophagy. CRISPR-mediated METTL3 knockout or circCSDE1 silencing markedly attenuated autophagosome formation and viral replication. This study uncovers a novel m6A-circRNA regulatory axis wherein CV subverts host epitranscriptomic machinery through METTL3/circCSDE1/miR-891b/BAG3 signaling to potentiate autophagy-dependent viral propagation, providing potential therapeutic targets for enteroviral infections.